Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Predictive Clinical-Radiomics Nomogram for Survival Prediction of Glioblastoma Using MRI.
Ammari S, Sallé de Chou R, Balleyguier C, Chouzenoux E, Touat M, Quillent A, Dumont S, Bockel S, Garcia GCTE, Elhaik M, Francois B, Borget V, Lassau N, Khettab M, Assi T. Ammari S, et al. Among authors: touat m. Diagnostics (Basel). 2021 Nov 4;11(11):2043. doi: 10.3390/diagnostics11112043. Diagnostics (Basel). 2021. PMID: 34829395 Free PMC article.
Sustained Tumor Control With MAPK Inhibition in BRAF V600-Mutant Adult Glial and Glioneuronal Tumors.
Berzero G, Bellu L, Baldini C, Ducray F, Guyon D, Eoli M, Silvani A, Dehais C, Idbaih A, Younan N, Nguyen-Them L, Gaillard S, Pasqualetti F, Lepage-Seydoux C, Sekkate S, Tresca P, Kas A, Gratieux J, Ammari S, Saragoussi E, Savatovsky J, Delattre JY, Hoang-Xuan K, Meyronet D, Villa C, Bielle F, Sanson M, Touat M, Di Stefano AL. Berzero G, et al. Among authors: touat m. Neurology. 2021 Aug 17;97(7):e673-e683. doi: 10.1212/WNL.0000000000012330. Epub 2021 Jun 4. Neurology. 2021. PMID: 34088874
Machine-Learning-Based Radiomics MRI Model for Survival Prediction of Recurrent Glioblastomas Treated with Bevacizumab.
Ammari S, Sallé de Chou R, Assi T, Touat M, Chouzenoux E, Quillent A, Limkin E, Dercle L, Hadchiti J, Elhaik M, Moalla S, Khettab M, Balleyguier C, Lassau N, Dumont S, Smolenschi C. Ammari S, et al. Among authors: touat m. Diagnostics (Basel). 2021 Jul 14;11(7):1263. doi: 10.3390/diagnostics11071263. Diagnostics (Basel). 2021. PMID: 34359346 Free PMC article.
Genome-driven medicine for patients with recurrent glioma enrolled in early phase trials.
Baldini C, Younan N, Castanon Alvarez E, Ammari S, Alentorn A, Dumont S, Frenel JS, Di Stefano AL, Louvel G, Michot JM, Bahleda R, Postel-Vinay S, Varga A, Marabelle A, Hollebecque A, Bielle F, Hoang-Xuan K, Delattre JY, Dhermain F, Sanson M, Soria JC, Idbaih A, Massard C, Touat M. Baldini C, et al. Among authors: touat m. Eur J Cancer. 2022 Mar;163:98-107. doi: 10.1016/j.ejca.2021.11.017. Epub 2022 Jan 18. Eur J Cancer. 2022. PMID: 35063776
Systematic review and meta-analysis of phase I/II targeted therapy combined with radiotherapy in patients with glioblastoma multiforme: quality of report, toxicity, and survival.
dos Santos MA, Pignon JP, Blanchard P, Lefeuvre D, Levy A, Touat M, Louvel G, Dhermain F, Soria JC, Deutsch E, Le Teuff G. dos Santos MA, et al. Among authors: touat m. J Neurooncol. 2015 Jun;123(2):307-14. doi: 10.1007/s11060-015-1802-5. Epub 2015 May 15. J Neurooncol. 2015. PMID: 25975195 Review.
Circulating oncometabolite D-2-hydroxyglutarate enantiomer is a surrogate marker of isocitrate dehydrogenase-mutated intrahepatic cholangiocarcinomas.
Delahousse J, Verlingue L, Broutin S, Legoupil C, Touat M, Doucet L, Ammari S, Lacroix L, Ducreux M, Scoazec JY, Malka D, Paci A, Hollebecque A. Delahousse J, et al. Among authors: touat m. Eur J Cancer. 2018 Feb;90:83-91. doi: 10.1016/j.ejca.2017.11.024. Epub 2018 Jan 4. Eur J Cancer. 2018. PMID: 29274619
Mechanisms and therapeutic implications of hypermutation in gliomas.
Touat M, Li YY, Boynton AN, Spurr LF, Iorgulescu JB, Bohrson CL, Cortes-Ciriano I, Birzu C, Geduldig JE, Pelton K, Lim-Fat MJ, Pal S, Ferrer-Luna R, Ramkissoon SH, Dubois F, Bellamy C, Currimjee N, Bonardi J, Qian K, Ho P, Malinowski S, Taquet L, Jones RE, Shetty A, Chow KH, Sharaf R, Pavlick D, Albacker LA, Younan N, Baldini C, Verreault M, Giry M, Guillerm E, Ammari S, Beuvon F, Mokhtari K, Alentorn A, Dehais C, Houillier C, Laigle-Donadey F, Psimaras D, Lee EQ, Nayak L, McFaline-Figueroa JR, Carpentier A, Cornu P, Capelle L, Mathon B, Barnholtz-Sloan JS, Chakravarti A, Bi WL, Chiocca EA, Fehnel KP, Alexandrescu S, Chi SN, Haas-Kogan D, Batchelor TT, Frampton GM, Alexander BM, Huang RY, Ligon AH, Coulet F, Delattre JY, Hoang-Xuan K, Meredith DM, Santagata S, Duval A, Sanson M, Cherniack AD, Wen PY, Reardon DA, Marabelle A, Park PJ, Idbaih A, Beroukhim R, Bandopadhayay P, Bielle F, Ligon KL. Touat M, et al. Nature. 2020 Apr;580(7804):517-523. doi: 10.1038/s41586-020-2209-9. Epub 2020 Apr 15. Nature. 2020. PMID: 32322066 Free PMC article.
Leptomeningeal Spread in Glioblastoma: Diagnostic and Therapeutic Challenges.
Birzu C, Tran S, Bielle F, Touat M, Mokhtari K, Younan N, Psimaras D, Hoang-Xuan K, Sanson M, Delattre JY, Idbaih A. Birzu C, et al. Among authors: touat m. Oncologist. 2020 Nov;25(11):e1763-e1776. doi: 10.1634/theoncologist.2020-0258. Epub 2020 Aug 31. Oncologist. 2020. PMID: 33394574 Free PMC article. Review.
Clinical utility of targeted next-generation sequencing assay in IDH-wildtype glioblastoma for therapy decision-making.
Lim-Fat MJ, Youssef GC, Touat M, Iorgulescu JB, Whorral S, Allen M, Rahman R, Chukwueke U, McFaline-Figueroa JR, Nayak L, Lee EQ, Batchelor TT, Arnaout O, Peruzzi PP, Chiocca EA, Reardon DA, Meredith D, Santagata S, Beroukhim R, Bi WL, Ligon KL, Wen PY. Lim-Fat MJ, et al. Among authors: touat m. Neuro Oncol. 2022 Jul 1;24(7):1140-1149. doi: 10.1093/neuonc/noab282. Neuro Oncol. 2022. PMID: 34878541 Free PMC article.
89 results